SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.09 Cr | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.09 Cr |
| Mar2024 | ₹9.84 Cr |
| Mar2020 | ₹-0.48 Cr |
| Mar2019 | ₹-0.18 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.09 Cr | Negative | |
| Mar2024 | ₹9.84 Cr | Positive | |
| Mar2020 | ₹-0.48 Cr | Negative | |
| Mar2019 | ₹-0.18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹596.5 Cr | 9.4% | 2.3% | -44.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 9.4% |
2.3% |
-44.2% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses